Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001104659-26-055725
Filing Date
2026-05-05
Accepted
2026-05-05 17:10:28
Documents
21
Period of Report
2026-06-30

Document Format Files

Seq Description Document Type Size
1 DEF 14A tm2611538-3_def14a.htm   iXBRL DEF 14A 915494
6 GRAPHIC lg_hyperion-4clr.jpg GRAPHIC 7183
7 GRAPHIC ic_member-bw.jpg GRAPHIC 1698
8 GRAPHIC ic_commchair-bw.jpg GRAPHIC 1839
9 GRAPHIC sg_hyunsujung-bwlr.jpg GRAPHIC 5244
10 GRAPHIC px_26hyperionproxy1pg01-4c.jpg GRAPHIC 338334
11 GRAPHIC px_26hyperionproxy1pg02-4c.jpg GRAPHIC 290240
  Complete submission text file 0001104659-26-055725.txt   3514407

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA hypd-20251231.xsd EX-101.SCH 8100
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE hypd-20251231_def.xml EX-101.DEF 2694
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE hypd-20251231_lab.xml EX-101.LAB 28079
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE hypd-20251231_pre.xml EX-101.PRE 6098
24 EXTRACTED XBRL INSTANCE DOCUMENT tm2611538-3_def14a_htm.xml XML 259814
Mailing Address 295 MADISON AVENUE SUITE 2400 NEW YORK NY 10017
Business Address 295 MADISON AVENUE SUITE 2400 NEW YORK NY 10017 833-393-6684
HYPERION DEFI, INC. (Filer) CIK: 0001682639 (see all company filings)

EIN.: 471178401 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-38365 | Film No.: 26944543
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)